BRPI0921084A2 - compostos, composição farmacêutica, uso de um composto, e, método de tratamento de dor - Google Patents

compostos, composição farmacêutica, uso de um composto, e, método de tratamento de dor

Info

Publication number
BRPI0921084A2
BRPI0921084A2 BRPI0921084A BRPI0921084A BRPI0921084A2 BR PI0921084 A2 BRPI0921084 A2 BR PI0921084A2 BR PI0921084 A BRPI0921084 A BR PI0921084A BR PI0921084 A BRPI0921084 A BR PI0921084A BR PI0921084 A2 BRPI0921084 A2 BR PI0921084A2
Authority
BR
Brazil
Prior art keywords
compounds
compound
pharmaceutical composition
treatment method
pain treatment
Prior art date
Application number
BRPI0921084A
Other languages
English (en)
Inventor
Ashvinkumar Dhirubhai Mistry
John Kinnaird Ferguson Maclean
Ronald Palin
Simon James Anthony Grove
Original Assignee
Organon Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Organon Nv filed Critical Organon Nv
Publication of BRPI0921084A2 publication Critical patent/BRPI0921084A2/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/10—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing aromatic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pain & Pain Management (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Rheumatology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
BRPI0921084A 2008-11-04 2009-11-03 compostos, composição farmacêutica, uso de um composto, e, método de tratamento de dor BRPI0921084A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP08168286 2008-11-04
PCT/EP2009/064490 WO2010052198A1 (en) 2008-11-04 2009-11-03 ( pyrrolidin-2 -yl) phenyl derivatives for use in the treatment of pain

Publications (1)

Publication Number Publication Date
BRPI0921084A2 true BRPI0921084A2 (pt) 2015-12-15

Family

ID=40251652

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0921084A BRPI0921084A2 (pt) 2008-11-04 2009-11-03 compostos, composição farmacêutica, uso de um composto, e, método de tratamento de dor

Country Status (13)

Country Link
EP (1) EP2356105B1 (pt)
JP (1) JP5642690B2 (pt)
KR (2) KR20150028342A (pt)
CN (1) CN102203077B (pt)
AR (1) AR074085A1 (pt)
AU (1) AU2009312855B2 (pt)
BR (1) BRPI0921084A2 (pt)
CA (1) CA2741332C (pt)
IL (1) IL212302A0 (pt)
MX (1) MX2011004750A (pt)
TW (1) TW201022233A (pt)
WO (1) WO2010052198A1 (pt)
ZA (1) ZA201103134B (pt)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2011076723A1 (en) 2009-12-22 2011-06-30 N.V. Organon Amino-heteroaryl derivatives as hcn blockers
KR20140014184A (ko) * 2011-02-25 2014-02-05 아이알엠 엘엘씨 Trk 억제제로서의 화합물 및 조성물

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL200427B1 (pl) * 1999-05-21 2009-01-30 Abbott Lab Związek aminoazacykliczny, kompozycja farmaceutyczna go zawierająca i jego zastosowanie
EP1297136A2 (en) * 2000-05-24 2003-04-02 Akzo Nobel N.V. Full length human hcn1 ih channel subunit and variants
MX2007004661A (es) * 2004-10-18 2007-06-22 Lilly Co Eli Derivados de 1-(hetero)aril-3-amino-pirrolidina para usarse como antagonistas del receptor mglur3.

Also Published As

Publication number Publication date
AU2009312855A1 (en) 2010-05-14
AR074085A1 (es) 2010-12-22
EP2356105A1 (en) 2011-08-17
ZA201103134B (en) 2012-01-25
CA2741332A1 (en) 2010-05-14
AU2009312855B2 (en) 2014-05-01
TW201022233A (en) 2010-06-16
JP5642690B2 (ja) 2014-12-17
KR101526643B1 (ko) 2015-06-05
CA2741332C (en) 2016-07-12
IL212302A0 (en) 2011-06-30
WO2010052198A1 (en) 2010-05-14
CN102203077A (zh) 2011-09-28
CN102203077B (zh) 2014-07-09
JP2012507490A (ja) 2012-03-29
EP2356105B1 (en) 2013-04-10
KR20110082174A (ko) 2011-07-18
KR20150028342A (ko) 2015-03-13
MX2011004750A (es) 2011-06-01

Similar Documents

Publication Publication Date Title
BRPI0810354A2 (pt) Composto, uso de um composto, composição farmacêutica, e, método de tratamento de um dispositivo de dor
BRPI0820568A2 (pt) Composto, composição farmacêutica, uso de um composto ou uma composição farmacêutica, e, método de tratamento de um humano ou animal
BRPI0907976A2 (pt) Composto, composição farmacêutica, uso de um composto, e, método para tratar ou prevenir doenças
BRPI0917458A2 (pt) composto, método de tratamento de doenças e condições, composição farmacêutica, método para tratar ou prevenir doença, e, uso de um composto
BRPI0917579A2 (pt) composto, composição farmacêutica, métodos, e, uso de um composto
BRPI0919942A2 (pt) Composto, composição farmacêutica, e, uso de um composto
BRPI0907562A2 (pt) composto, composição farmacêutica, e, uso de um composto
BR112012022878A2 (pt) composto, composição farmacêutica, uso do compostos e método de tratamento
BRPI0921375A2 (pt) composto, composição farmacêutica, e, uso de um composto
BRPI0821115A2 (pt) Composto derivado de aminotriazol, medicamento, composição farmacêutica e uso do composto
BRPI0918360A2 (pt) composto, composição farmacêutica e usos de um composto
BRPI0912348A2 (pt) composto de 3-aminocarbazol, composição farmacêutica, método para preparar um composto de 3-aminocarbazol, uso de um composto de 3-aminocarbazol, e, método para tratar ou prevenir doenças
BRPI0818244A2 (pt) Composto, composição farmacêutica, uso de um composto, e, método para tratamento de um distúrbio ou doença
BR112012022879A2 (pt) composto, composição farmacêutica, uso do composto e método de tratamento
BRPI0810696A2 (pt) Composto, composição farmacêutica, e, uso de um composto
BRPI0913585A2 (pt) composto, método para fabricar um composto, composição farmacêutica, uso de um composto, e, método para o tratamento ou prevenção de distúrbios
BRPI0813001A2 (pt) composto, método de tratamento ou profilaxia de dor neuropática e composição farmacêutica
BRPI0907974A2 (pt) Composto, composição farmacêutica, uso de um composto, e, método para tratar ou prevenir doenças
BRPI0921879A2 (pt) composto, composição farmacêutica , e, uso de um composto
BRPI0911685A2 (pt) composto, método para o tratamento de uma doença, uso de um composto, composição farmacêutica, e, kit
BRPI0815493A2 (pt) Composto, uso de um composto, composição faramcêutica, método para a terapia de dor, e, processo para preparar um composto.
BRPI0908635A2 (pt) composto, composição farmacêutica e método de tratamento de câncer
EP2429987A4 (en) AMIDE COMPOUND, PROCESS FOR PREPARING THE SAME, AND PHARMACEUTICAL COMPOSITION COMPRISING THE SAME
BRPI0906937A2 (pt) composto, composição farmacêutica, e, uso de um composto
BRPI0914371A2 (pt) "composto, composição farmacêutica, uso de um composto, método para tratar um indivíduo, e produto de combinação"

Legal Events

Date Code Title Description
B25A Requested transfer of rights approved

Owner name: MSD OSS B.V. (NL)

B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B25A Requested transfer of rights approved

Owner name: ORGANON BIOSCIENCES NEDERLAND B.V. (NL)

B25A Requested transfer of rights approved

Owner name: MERCK SHARP AND DOHME B.V. (NL)

B07E Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]
B11B Dismissal acc. art. 36, par 1 of ipl - no reply within 90 days to fullfil the necessary requirements